skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: UNH is my only US healthcare name. Could you please suggest 2 other names to add today with a balance of growth and safety. Thank you.
Read Answer Asked by Cheryl on November 08, 2022
Q: Could you please comment on earnings and whether buy, sell or hold? If you don't like what companies would you prefer? Thank you!
Read Answer Asked by Neil on November 04, 2022
Q: On October 31 the answer to a question I read compared LNTH to LLY as LNTH was a lot cheaper and would have more upside than LLY and big named actors were using the product as opposed to plastic surgery. Then I read very recently Peter's 5 2022 best percentage gains as having Lantheus Holdings (LNTH) first as he seemed very upbeat on it and mentioned it could pause a bit after having all these gains. Here I am 3 days into owning it and it is down over 12%. I read on my online account Nov 3 earnings were reasonably good but I also read on BNN Bloomberg that their earnings were not coming out until later so am I right about the earnings coming out today and were they worse than what I interpreted? I cannot interpret these earnings reports like 5i can. After being down that much in such a short period of time, I am wondering if I should sell or hold? Thank you,
Read Answer Asked by Dennis on November 04, 2022
Q: I have chosen WELL as a positive example but I am puzzled by the apparent lack of performance for the sector. We have a health care problem; scads of people do not have a family doctor. I know the difficulty involves more than the services WELL can provide BUT I would have thought services such as those provided by companies like WELL would have been in demand, would have been able to provide some relief, their valuations would have prospered even during their development, and investors would have seen some benefits. Yet the sector valuations flounder. What am I missing?
Read Answer Asked by Mike on November 02, 2022
Q: ,After the 2 divestments in a few weeks DOC have recouped 9M$. Were those divisions cash flow positive? Will this new intake of cash help them navigate through this bad period and until the stock moves up before they have to issue stock. What would be their cash burn rate after the sale of these 2 divisions? I assume those were net positives for the company.

DEEEEEP under water, I don't expect to ever get back in the money unless I keep the stock several years if they make it there. In a registered account there is no point for tax selling. Bad investment, bad timing. Do you have an answer that can make me smile again? LOL LOL
Thank you

Yves
Read Answer Asked by Yves on November 02, 2022
Q: In a previous comment you stated "Five stocks that we feel will perform well over a long term period are: TSU, NVDA, SHOP, CSU, and INMD." In regards to INMD, what are your thoughts on other competitors in medical aesthetics, such as CUTR, ABBV, SIEN, or others I may have left out? What makes INMD more desirable in your opinion?
Read Answer Asked by Andrew on November 01, 2022
Q: Hello 5i team,
With NBLY having 284 pharmacies. A quick google search says that there are 11,356 community pharmacies across Canada which would be <3% for NBLY. I am guessing that most of these pharmacies are the bigger fish like shoppers and Rexal (correct me if I'm wrong). I was wondering how much NBLY can grow in the coming 5 years.

Roughly how much of the pharmacy pool can NBLY aquire for growth?

Andrew
Read Answer Asked by Andrew on November 01, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!